Global Drug Eluting Balloon Catheters Market Growth 2026-2032
The global Drug Eluting Balloon Catheters market size is predicted to grow from US$ 1487 million in 2025 to US$ 3521 million in 2032; it is expected to grow at a CAGR of 13.0% from 2026 to 2032.
Drug eluting balloon catheters (DEB; commonly referred to as drug-coated balloon catheters, DCB) are percutaneous endovascular devices with an antiproliferative drug (typically paclitaxel or ?limus? agents) and an excipient/carrier layer coated on the balloon surface. During angioplasty, the catheter delivers both mechanical luminal gain and rapid, targeted drug transfer into the vessel wall to suppress neointimal hyperplasia and reduce restenosis?while embracing a ?leave nothing behind? strategy that avoids permanent implants and their long-term inflammatory/thrombotic burden. DEB/DCB catheters are used across PAD, dialysis access maintenance, and selected coronary scenarios such as in-stent restenosis and small-vessel disease, increasingly integrated with lesion preparation and intravascular imaging to enable more refined vascular repair.In 2025, global Drug eluting balloon catheters production reached approximately1528 k units and price is 995 USD/Unit.The average gross profit margin of this product is 73%.
Drug eluting balloon catheters are benefiting from a structural shift ?from implantation to repair? and ?from single devices to integrated solutions.? On the regulatory front, the U.S. FDA?s updated assessment on paclitaxel-coated devices for PAD has provided a clearer risk boundary, making hospital governance and clinical pathway adoption more actionable. Meanwhile, leading multinationals continue to highlight DCB portfolios and their commercial traction in annual reporting, signaling rising strategic weight within peripheral and broader cardiovascular franchises. With expanding indications, iterative improvements in coating/excipient systems and drug-transfer performance, and accumulating real-world evidence, DEB/DCB catheters are moving from an ?adjunct option? toward a more standardized tool set that can scale across centers.
Competition has shifted from ?can you build it? to ?can you scale it with compliance and reproducibility.? In China, national-level communications and public notices on centralized volume-based procurement and winning results have been released, accelerating a market phase defined by price constraints, supply assurance, and quality systems. Brokerage commentary broadly notes that procurement reforms can standardize purchasing and usage and improve market order, but near-term price pressure may compress margins?forcing manufacturers to rebuild value through yield improvement, scaled manufacturing, and differentiated clinical evidence. Globally, scrutiny on long-term outcomes and net clinical benefit will persist, making ?evidence + risk management + manufacturing consistency? the three enduring pillars.
Downstream demand is moving toward bundled therapy: hospitals increasingly prioritize fewer reinterventions, shorter length of stay, and procedural efficiency?driving more routine combination of DEB/DCB with lesion preparation devices, specialty balloons, and intravascular imaging (IVUS/OCT). At the same time, broader national procurement coverage encourages centers to build repeatable, compliant standard-of-care pathways and device combinations, shifting growth from ?operator preference?driven? to ?pathway and discipline-building?driven.? For manufacturers, the next growth curve is less about a single catheter and more about delivering an adoptable clinical solution supported by evidence communication, training systems, and follow-up tools that reinforce customer stickiness.
Upstream value is defined not only by materials but by a controlled coating process chain and consistent batch release. Key inputs include balloon and catheter polymers (balloon films and multi-durometer shafts), drug APIs (paclitaxel or ?limus? agents) and excipient/carrier systems, coating solvents and metrology consumables, sterile barrier packaging, and sterilization services. Under simultaneous procurement pressure and global compliance expectations, upstream partners must deliver medical-grade traceability, robust change control, and clean manufacturing. Any drift in drug crystallinity, excipient formulation, or coating process window can alter drug-transfer performance and batch stability?directly impacting clinical reputation and commercialization efficiency. In line with brokerage emphasis on ?cost efficiency and supply assurance? as core competitive variables, deep upstream integration and platformized process capability are becoming decisive differentiators.
LP Information, Inc. (LPI) ' newest research report, the ?Drug Eluting Balloon Catheters Industry Forecast? looks at past sales and reviews total world Drug Eluting Balloon Catheters sales in 2025, providing a comprehensive analysis by region and market sector of projected Drug Eluting Balloon Catheters sales for 2026 through 2032. With Drug Eluting Balloon Catheters sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug Eluting Balloon Catheters industry.
This Insight Report provides a comprehensive analysis of the global Drug Eluting Balloon Catheters landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug Eluting Balloon Catheters portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Drug Eluting Balloon Catheters market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug Eluting Balloon Catheters and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug Eluting Balloon Catheters.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug Eluting Balloon Catheters market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Drug eluting balloon catheters (DEB; commonly referred to as drug-coated balloon catheters, DCB) are percutaneous endovascular devices with an antiproliferative drug (typically paclitaxel or ?limus? agents) and an excipient/carrier layer coated on the balloon surface. During angioplasty, the catheter delivers both mechanical luminal gain and rapid, targeted drug transfer into the vessel wall to suppress neointimal hyperplasia and reduce restenosis?while embracing a ?leave nothing behind? strategy that avoids permanent implants and their long-term inflammatory/thrombotic burden. DEB/DCB catheters are used across PAD, dialysis access maintenance, and selected coronary scenarios such as in-stent restenosis and small-vessel disease, increasingly integrated with lesion preparation and intravascular imaging to enable more refined vascular repair.In 2025, global Drug eluting balloon catheters production reached approximately1528 k units and price is 995 USD/Unit.The average gross profit margin of this product is 73%.
Drug eluting balloon catheters are benefiting from a structural shift ?from implantation to repair? and ?from single devices to integrated solutions.? On the regulatory front, the U.S. FDA?s updated assessment on paclitaxel-coated devices for PAD has provided a clearer risk boundary, making hospital governance and clinical pathway adoption more actionable. Meanwhile, leading multinationals continue to highlight DCB portfolios and their commercial traction in annual reporting, signaling rising strategic weight within peripheral and broader cardiovascular franchises. With expanding indications, iterative improvements in coating/excipient systems and drug-transfer performance, and accumulating real-world evidence, DEB/DCB catheters are moving from an ?adjunct option? toward a more standardized tool set that can scale across centers.
Competition has shifted from ?can you build it? to ?can you scale it with compliance and reproducibility.? In China, national-level communications and public notices on centralized volume-based procurement and winning results have been released, accelerating a market phase defined by price constraints, supply assurance, and quality systems. Brokerage commentary broadly notes that procurement reforms can standardize purchasing and usage and improve market order, but near-term price pressure may compress margins?forcing manufacturers to rebuild value through yield improvement, scaled manufacturing, and differentiated clinical evidence. Globally, scrutiny on long-term outcomes and net clinical benefit will persist, making ?evidence + risk management + manufacturing consistency? the three enduring pillars.
Downstream demand is moving toward bundled therapy: hospitals increasingly prioritize fewer reinterventions, shorter length of stay, and procedural efficiency?driving more routine combination of DEB/DCB with lesion preparation devices, specialty balloons, and intravascular imaging (IVUS/OCT). At the same time, broader national procurement coverage encourages centers to build repeatable, compliant standard-of-care pathways and device combinations, shifting growth from ?operator preference?driven? to ?pathway and discipline-building?driven.? For manufacturers, the next growth curve is less about a single catheter and more about delivering an adoptable clinical solution supported by evidence communication, training systems, and follow-up tools that reinforce customer stickiness.
Upstream value is defined not only by materials but by a controlled coating process chain and consistent batch release. Key inputs include balloon and catheter polymers (balloon films and multi-durometer shafts), drug APIs (paclitaxel or ?limus? agents) and excipient/carrier systems, coating solvents and metrology consumables, sterile barrier packaging, and sterilization services. Under simultaneous procurement pressure and global compliance expectations, upstream partners must deliver medical-grade traceability, robust change control, and clean manufacturing. Any drift in drug crystallinity, excipient formulation, or coating process window can alter drug-transfer performance and batch stability?directly impacting clinical reputation and commercialization efficiency. In line with brokerage emphasis on ?cost efficiency and supply assurance? as core competitive variables, deep upstream integration and platformized process capability are becoming decisive differentiators.
LP Information, Inc. (LPI) ' newest research report, the ?Drug Eluting Balloon Catheters Industry Forecast? looks at past sales and reviews total world Drug Eluting Balloon Catheters sales in 2025, providing a comprehensive analysis by region and market sector of projected Drug Eluting Balloon Catheters sales for 2026 through 2032. With Drug Eluting Balloon Catheters sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug Eluting Balloon Catheters industry.
This Insight Report provides a comprehensive analysis of the global Drug Eluting Balloon Catheters landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug Eluting Balloon Catheters portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Drug Eluting Balloon Catheters market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug Eluting Balloon Catheters and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug Eluting Balloon Catheters.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug Eluting Balloon Catheters market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Peripheral DEB
- Coronary DEB
- In-Stent Restenosi
- De Novo
- Small Vessel
- Cardiac Catheterization Lab
- Hospital
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- B. Braun
- Medtronic
- Boston Scientific
- BD
- Yinyi Biotechnology
- Acotec
- Philips
- Lepu Medical
- Eurocor
- MicroPort Medical
- Teleflex
- What is the 10-year outlook for the global Drug Eluting Balloon Catheters market?
- What factors are driving Drug Eluting Balloon Catheters market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How doDrug Eluting Balloon Catheters market opportunities vary by end market size?
- How does Drug Eluting Balloon Catheters break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drug Eluting Balloon Catheters Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Drug Eluting Balloon Catheters by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Drug Eluting Balloon Catheters by Country/Region, 2021, 2025 & 2032
2.2 Drug Eluting Balloon Catheters Segment by Type
2.2.1 Peripheral DEB
2.2.2 Coronary DEB
2.2.3 Drug Eluting Balloon Catheters Sales by Type
2.2.3.1 Global Drug Eluting Balloon Catheters Sales Market Share by Type (2021-2026)
2.2.3.2 Global Drug Eluting Balloon Catheters Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Drug Eluting Balloon Catheters Sale Price by Type (2021-2026)
2.3 Drug Eluting Balloon Catheters Segment by Balloon Platform Mechanics
2.3.1 In-Stent Restenosi
2.3.2 De Novo
2.3.3 Small Vessel
2.3.4 Drug Eluting Balloon Catheters Sales by Balloon Platform Mechanics
2.3.4.1 Global Drug Eluting Balloon Catheters Sales Market Share by Balloon Platform Mechanics (2021-2026)
2.3.4.2 Global Drug Eluting Balloon Catheters Revenue and Market Share by Balloon Platform Mechanics (2021-2026)
2.3.4.3 Global Drug Eluting Balloon Catheters Sale Price by Balloon Platform Mechanics (2021-2026)
2.4 Drug Eluting Balloon Catheters Segment by Application
2.4.1 Cardiac Catheterization Lab
2.4.2 Hospital
2.4.3 Other
2.4.4 Drug Eluting Balloon Catheters Sales by Application
2.4.4.1 Global Drug Eluting Balloon Catheters Sale Market Share by Application (2021-2026)
2.4.4.2 Global Drug Eluting Balloon Catheters Revenue and Market Share by Application (2021-2026)
2.4.4.3 Global Drug Eluting Balloon Catheters Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Drug Eluting Balloon Catheters Breakdown Data by Company
3.1.1 Global Drug Eluting Balloon Catheters Annual Sales by Company (2021-2026)
3.1.2 Global Drug Eluting Balloon Catheters Sales Market Share by Company (2021-2026)
3.2 Global Drug Eluting Balloon Catheters Annual Revenue by Company (2021-2026)
3.2.1 Global Drug Eluting Balloon Catheters Revenue by Company (2021-2026)
3.2.2 Global Drug Eluting Balloon Catheters Revenue Market Share by Company (2021-2026)
3.3 Global Drug Eluting Balloon Catheters Sale Price by Company
3.4 Key Manufacturers Drug Eluting Balloon Catheters Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Drug Eluting Balloon Catheters Product Location Distribution
3.4.2 Players Drug Eluting Balloon Catheters Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR DRUG ELUTING BALLOON CATHETERS BY GEOGRAPHIC REGION
4.1 World Historic Drug Eluting Balloon Catheters Market Size by Geographic Region (2021-2026)
4.1.1 Global Drug Eluting Balloon Catheters Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Drug Eluting Balloon Catheters Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Drug Eluting Balloon Catheters Market Size by Country/Region (2021-2026)
4.2.1 Global Drug Eluting Balloon Catheters Annual Sales by Country/Region (2021-2026)
4.2.2 Global Drug Eluting Balloon Catheters Annual Revenue by Country/Region (2021-2026)
4.3 Americas Drug Eluting Balloon Catheters Sales Growth
4.4 APAC Drug Eluting Balloon Catheters Sales Growth
4.5 Europe Drug Eluting Balloon Catheters Sales Growth
4.6 Middle East & Africa Drug Eluting Balloon Catheters Sales Growth
5 AMERICAS
5.1 Americas Drug Eluting Balloon Catheters Sales by Country
5.1.1 Americas Drug Eluting Balloon Catheters Sales by Country (2021-2026)
5.1.2 Americas Drug Eluting Balloon Catheters Revenue by Country (2021-2026)
5.2 Americas Drug Eluting Balloon Catheters Sales by Type (2021-2026)
5.3 Americas Drug Eluting Balloon Catheters Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug Eluting Balloon Catheters Sales by Region
6.1.1 APAC Drug Eluting Balloon Catheters Sales by Region (2021-2026)
6.1.2 APAC Drug Eluting Balloon Catheters Revenue by Region (2021-2026)
6.2 APAC Drug Eluting Balloon Catheters Sales by Type (2021-2026)
6.3 APAC Drug Eluting Balloon Catheters Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Drug Eluting Balloon Catheters by Country
7.1.1 Europe Drug Eluting Balloon Catheters Sales by Country (2021-2026)
7.1.2 Europe Drug Eluting Balloon Catheters Revenue by Country (2021-2026)
7.2 Europe Drug Eluting Balloon Catheters Sales by Type (2021-2026)
7.3 Europe Drug Eluting Balloon Catheters Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drug Eluting Balloon Catheters by Country
8.1.1 Middle East & Africa Drug Eluting Balloon Catheters Sales by Country (2021-2026)
8.1.2 Middle East & Africa Drug Eluting Balloon Catheters Revenue by Country (2021-2026)
8.2 Middle East & Africa Drug Eluting Balloon Catheters Sales by Type (2021-2026)
8.3 Middle East & Africa Drug Eluting Balloon Catheters Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Drug Eluting Balloon Catheters
10.3 Manufacturing Process Analysis of Drug Eluting Balloon Catheters
10.4 Industry Chain Structure of Drug Eluting Balloon Catheters
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Drug Eluting Balloon Catheters Distributors
11.3 Drug Eluting Balloon Catheters Customer
12 WORLD FORECAST REVIEW FOR DRUG ELUTING BALLOON CATHETERS BY GEOGRAPHIC REGION
12.1 Global Drug Eluting Balloon Catheters Market Size Forecast by Region
12.1.1 Global Drug Eluting Balloon Catheters Forecast by Region (2027-2032)
12.1.2 Global Drug Eluting Balloon Catheters Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Drug Eluting Balloon Catheters Forecast by Type (2027-2032)
12.7 Global Drug Eluting Balloon Catheters Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 B. Braun
13.1.1 B. Braun Company Information
13.1.2 B. Braun Drug Eluting Balloon Catheters Product Portfolios and Specifications
13.1.3 B. Braun Drug Eluting Balloon Catheters Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 B. Braun Main Business Overview
13.1.5 B. Braun Latest Developments
13.2 Medtronic
13.2.1 Medtronic Company Information
13.2.2 Medtronic Drug Eluting Balloon Catheters Product Portfolios and Specifications
13.2.3 Medtronic Drug Eluting Balloon Catheters Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Medtronic Main Business Overview
13.2.5 Medtronic Latest Developments
13.3 Boston Scientific
13.3.1 Boston Scientific Company Information
13.3.2 Boston Scientific Drug Eluting Balloon Catheters Product Portfolios and Specifications
13.3.3 Boston Scientific Drug Eluting Balloon Catheters Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Boston Scientific Main Business Overview
13.3.5 Boston Scientific Latest Developments
13.4 BD
13.4.1 BD Company Information
13.4.2 BD Drug Eluting Balloon Catheters Product Portfolios and Specifications
13.4.3 BD Drug Eluting Balloon Catheters Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 BD Main Business Overview
13.4.5 BD Latest Developments
13.5 Yinyi Biotechnology
13.5.1 Yinyi Biotechnology Company Information
13.5.2 Yinyi Biotechnology Drug Eluting Balloon Catheters Product Portfolios and Specifications
13.5.3 Yinyi Biotechnology Drug Eluting Balloon Catheters Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Yinyi Biotechnology Main Business Overview
13.5.5 Yinyi Biotechnology Latest Developments
13.6 Acotec
13.6.1 Acotec Company Information
13.6.2 Acotec Drug Eluting Balloon Catheters Product Portfolios and Specifications
13.6.3 Acotec Drug Eluting Balloon Catheters Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Acotec Main Business Overview
13.6.5 Acotec Latest Developments
13.7 Philips
13.7.1 Philips Company Information
13.7.2 Philips Drug Eluting Balloon Catheters Product Portfolios and Specifications
13.7.3 Philips Drug Eluting Balloon Catheters Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Philips Main Business Overview
13.7.5 Philips Latest Developments
13.8 Lepu Medical
13.8.1 Lepu Medical Company Information
13.8.2 Lepu Medical Drug Eluting Balloon Catheters Product Portfolios and Specifications
13.8.3 Lepu Medical Drug Eluting Balloon Catheters Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Lepu Medical Main Business Overview
13.8.5 Lepu Medical Latest Developments
13.9 Eurocor
13.9.1 Eurocor Company Information
13.9.2 Eurocor Drug Eluting Balloon Catheters Product Portfolios and Specifications
13.9.3 Eurocor Drug Eluting Balloon Catheters Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Eurocor Main Business Overview
13.9.5 Eurocor Latest Developments
13.10 MicroPort Medical
13.10.1 MicroPort Medical Company Information
13.10.2 MicroPort Medical Drug Eluting Balloon Catheters Product Portfolios and Specifications
13.10.3 MicroPort Medical Drug Eluting Balloon Catheters Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 MicroPort Medical Main Business Overview
13.10.5 MicroPort Medical Latest Developments
13.11 Teleflex
13.11.1 Teleflex Company Information
13.11.2 Teleflex Drug Eluting Balloon Catheters Product Portfolios and Specifications
13.11.3 Teleflex Drug Eluting Balloon Catheters Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Teleflex Main Business Overview
13.11.5 Teleflex Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drug Eluting Balloon Catheters Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Drug Eluting Balloon Catheters by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Drug Eluting Balloon Catheters by Country/Region, 2021, 2025 & 2032
2.2 Drug Eluting Balloon Catheters Segment by Type
2.2.1 Peripheral DEB
2.2.2 Coronary DEB
2.2.3 Drug Eluting Balloon Catheters Sales by Type
2.2.3.1 Global Drug Eluting Balloon Catheters Sales Market Share by Type (2021-2026)
2.2.3.2 Global Drug Eluting Balloon Catheters Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Drug Eluting Balloon Catheters Sale Price by Type (2021-2026)
2.3 Drug Eluting Balloon Catheters Segment by Balloon Platform Mechanics
2.3.1 In-Stent Restenosi
2.3.2 De Novo
2.3.3 Small Vessel
2.3.4 Drug Eluting Balloon Catheters Sales by Balloon Platform Mechanics
2.3.4.1 Global Drug Eluting Balloon Catheters Sales Market Share by Balloon Platform Mechanics (2021-2026)
2.3.4.2 Global Drug Eluting Balloon Catheters Revenue and Market Share by Balloon Platform Mechanics (2021-2026)
2.3.4.3 Global Drug Eluting Balloon Catheters Sale Price by Balloon Platform Mechanics (2021-2026)
2.4 Drug Eluting Balloon Catheters Segment by Application
2.4.1 Cardiac Catheterization Lab
2.4.2 Hospital
2.4.3 Other
2.4.4 Drug Eluting Balloon Catheters Sales by Application
2.4.4.1 Global Drug Eluting Balloon Catheters Sale Market Share by Application (2021-2026)
2.4.4.2 Global Drug Eluting Balloon Catheters Revenue and Market Share by Application (2021-2026)
2.4.4.3 Global Drug Eluting Balloon Catheters Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Drug Eluting Balloon Catheters Breakdown Data by Company
3.1.1 Global Drug Eluting Balloon Catheters Annual Sales by Company (2021-2026)
3.1.2 Global Drug Eluting Balloon Catheters Sales Market Share by Company (2021-2026)
3.2 Global Drug Eluting Balloon Catheters Annual Revenue by Company (2021-2026)
3.2.1 Global Drug Eluting Balloon Catheters Revenue by Company (2021-2026)
3.2.2 Global Drug Eluting Balloon Catheters Revenue Market Share by Company (2021-2026)
3.3 Global Drug Eluting Balloon Catheters Sale Price by Company
3.4 Key Manufacturers Drug Eluting Balloon Catheters Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Drug Eluting Balloon Catheters Product Location Distribution
3.4.2 Players Drug Eluting Balloon Catheters Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR DRUG ELUTING BALLOON CATHETERS BY GEOGRAPHIC REGION
4.1 World Historic Drug Eluting Balloon Catheters Market Size by Geographic Region (2021-2026)
4.1.1 Global Drug Eluting Balloon Catheters Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Drug Eluting Balloon Catheters Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Drug Eluting Balloon Catheters Market Size by Country/Region (2021-2026)
4.2.1 Global Drug Eluting Balloon Catheters Annual Sales by Country/Region (2021-2026)
4.2.2 Global Drug Eluting Balloon Catheters Annual Revenue by Country/Region (2021-2026)
4.3 Americas Drug Eluting Balloon Catheters Sales Growth
4.4 APAC Drug Eluting Balloon Catheters Sales Growth
4.5 Europe Drug Eluting Balloon Catheters Sales Growth
4.6 Middle East & Africa Drug Eluting Balloon Catheters Sales Growth
5 AMERICAS
5.1 Americas Drug Eluting Balloon Catheters Sales by Country
5.1.1 Americas Drug Eluting Balloon Catheters Sales by Country (2021-2026)
5.1.2 Americas Drug Eluting Balloon Catheters Revenue by Country (2021-2026)
5.2 Americas Drug Eluting Balloon Catheters Sales by Type (2021-2026)
5.3 Americas Drug Eluting Balloon Catheters Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug Eluting Balloon Catheters Sales by Region
6.1.1 APAC Drug Eluting Balloon Catheters Sales by Region (2021-2026)
6.1.2 APAC Drug Eluting Balloon Catheters Revenue by Region (2021-2026)
6.2 APAC Drug Eluting Balloon Catheters Sales by Type (2021-2026)
6.3 APAC Drug Eluting Balloon Catheters Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Drug Eluting Balloon Catheters by Country
7.1.1 Europe Drug Eluting Balloon Catheters Sales by Country (2021-2026)
7.1.2 Europe Drug Eluting Balloon Catheters Revenue by Country (2021-2026)
7.2 Europe Drug Eluting Balloon Catheters Sales by Type (2021-2026)
7.3 Europe Drug Eluting Balloon Catheters Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drug Eluting Balloon Catheters by Country
8.1.1 Middle East & Africa Drug Eluting Balloon Catheters Sales by Country (2021-2026)
8.1.2 Middle East & Africa Drug Eluting Balloon Catheters Revenue by Country (2021-2026)
8.2 Middle East & Africa Drug Eluting Balloon Catheters Sales by Type (2021-2026)
8.3 Middle East & Africa Drug Eluting Balloon Catheters Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Drug Eluting Balloon Catheters
10.3 Manufacturing Process Analysis of Drug Eluting Balloon Catheters
10.4 Industry Chain Structure of Drug Eluting Balloon Catheters
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Drug Eluting Balloon Catheters Distributors
11.3 Drug Eluting Balloon Catheters Customer
12 WORLD FORECAST REVIEW FOR DRUG ELUTING BALLOON CATHETERS BY GEOGRAPHIC REGION
12.1 Global Drug Eluting Balloon Catheters Market Size Forecast by Region
12.1.1 Global Drug Eluting Balloon Catheters Forecast by Region (2027-2032)
12.1.2 Global Drug Eluting Balloon Catheters Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Drug Eluting Balloon Catheters Forecast by Type (2027-2032)
12.7 Global Drug Eluting Balloon Catheters Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 B. Braun
13.1.1 B. Braun Company Information
13.1.2 B. Braun Drug Eluting Balloon Catheters Product Portfolios and Specifications
13.1.3 B. Braun Drug Eluting Balloon Catheters Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 B. Braun Main Business Overview
13.1.5 B. Braun Latest Developments
13.2 Medtronic
13.2.1 Medtronic Company Information
13.2.2 Medtronic Drug Eluting Balloon Catheters Product Portfolios and Specifications
13.2.3 Medtronic Drug Eluting Balloon Catheters Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Medtronic Main Business Overview
13.2.5 Medtronic Latest Developments
13.3 Boston Scientific
13.3.1 Boston Scientific Company Information
13.3.2 Boston Scientific Drug Eluting Balloon Catheters Product Portfolios and Specifications
13.3.3 Boston Scientific Drug Eluting Balloon Catheters Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Boston Scientific Main Business Overview
13.3.5 Boston Scientific Latest Developments
13.4 BD
13.4.1 BD Company Information
13.4.2 BD Drug Eluting Balloon Catheters Product Portfolios and Specifications
13.4.3 BD Drug Eluting Balloon Catheters Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 BD Main Business Overview
13.4.5 BD Latest Developments
13.5 Yinyi Biotechnology
13.5.1 Yinyi Biotechnology Company Information
13.5.2 Yinyi Biotechnology Drug Eluting Balloon Catheters Product Portfolios and Specifications
13.5.3 Yinyi Biotechnology Drug Eluting Balloon Catheters Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Yinyi Biotechnology Main Business Overview
13.5.5 Yinyi Biotechnology Latest Developments
13.6 Acotec
13.6.1 Acotec Company Information
13.6.2 Acotec Drug Eluting Balloon Catheters Product Portfolios and Specifications
13.6.3 Acotec Drug Eluting Balloon Catheters Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Acotec Main Business Overview
13.6.5 Acotec Latest Developments
13.7 Philips
13.7.1 Philips Company Information
13.7.2 Philips Drug Eluting Balloon Catheters Product Portfolios and Specifications
13.7.3 Philips Drug Eluting Balloon Catheters Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Philips Main Business Overview
13.7.5 Philips Latest Developments
13.8 Lepu Medical
13.8.1 Lepu Medical Company Information
13.8.2 Lepu Medical Drug Eluting Balloon Catheters Product Portfolios and Specifications
13.8.3 Lepu Medical Drug Eluting Balloon Catheters Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Lepu Medical Main Business Overview
13.8.5 Lepu Medical Latest Developments
13.9 Eurocor
13.9.1 Eurocor Company Information
13.9.2 Eurocor Drug Eluting Balloon Catheters Product Portfolios and Specifications
13.9.3 Eurocor Drug Eluting Balloon Catheters Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Eurocor Main Business Overview
13.9.5 Eurocor Latest Developments
13.10 MicroPort Medical
13.10.1 MicroPort Medical Company Information
13.10.2 MicroPort Medical Drug Eluting Balloon Catheters Product Portfolios and Specifications
13.10.3 MicroPort Medical Drug Eluting Balloon Catheters Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 MicroPort Medical Main Business Overview
13.10.5 MicroPort Medical Latest Developments
13.11 Teleflex
13.11.1 Teleflex Company Information
13.11.2 Teleflex Drug Eluting Balloon Catheters Product Portfolios and Specifications
13.11.3 Teleflex Drug Eluting Balloon Catheters Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Teleflex Main Business Overview
13.11.5 Teleflex Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Drug Eluting Balloon Catheters Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Drug Eluting Balloon Catheters Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Peripheral DEB
Table 4. Major Players of Coronary DEB
Table 5. Global Drug Eluting Balloon Catheters Sales by Type (2021-2026) & (K Units)
Table 6. Global Drug Eluting Balloon Catheters Sales Market Share by Type (2021-2026)
Table 7. Global Drug Eluting Balloon Catheters Revenue by Type (2021-2026) & ($ million)
Table 8. Global Drug Eluting Balloon Catheters Revenue Market Share by Type (2021-2026)
Table 9. Global Drug Eluting Balloon Catheters Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of In-Stent Restenosi
Table 11. Major Players of De Novo
Table 12. Major Players of Small Vessel
Table 13. Global Drug Eluting Balloon Catheters Sales by Balloon Platform Mechanics (2021-2026) & (K Units)
Table 14. Global Drug Eluting Balloon Catheters Sales Market Share by Balloon Platform Mechanics (2021-2026)
Table 15. Global Drug Eluting Balloon Catheters Revenue by Balloon Platform Mechanics (2021-2026) & ($ million)
Table 16. Global Drug Eluting Balloon Catheters Revenue Market Share by Balloon Platform Mechanics (2021-2026)
Table 17. Global Drug Eluting Balloon Catheters Sale Price by Balloon Platform Mechanics (2021-2026) & (US$/Unit)
Table 18. Major Players of Semi-/Compliant
Table 19. Major Players of Non-compliant
Table 20. Major Players of Other
Table 21. Global Drug Eluting Balloon Catheters Sale by Application (2021-2026) & (K Units)
Table 22. Global Drug Eluting Balloon Catheters Sale Market Share by Application (2021-2026)
Table 23. Global Drug Eluting Balloon Catheters Revenue by Application (2021-2026) & ($ million)
Table 24. Global Drug Eluting Balloon Catheters Revenue Market Share by Application (2021-2026)
Table 25. Global Drug Eluting Balloon Catheters Sale Price by Application (2021-2026) & (US$/Unit)
Table 26. Global Drug Eluting Balloon Catheters Sales by Company (2021-2026) & (K Units)
Table 27. Global Drug Eluting Balloon Catheters Sales Market Share by Company (2021-2026)
Table 28. Global Drug Eluting Balloon Catheters Revenue by Company (2021-2026) & ($ millions)
Table 29. Global Drug Eluting Balloon Catheters Revenue Market Share by Company (2021-2026)
Table 30. Global Drug Eluting Balloon Catheters Sale Price by Company (2021-2026) & (US$/Unit)
Table 31. Key Manufacturers Drug Eluting Balloon Catheters Producing Area Distribution and Sales Area
Table 32. Players Drug Eluting Balloon Catheters Products Offered
Table 33. Drug Eluting Balloon Catheters Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 34. New Products and Potential Entrants
Table 35. Market M&A Activity & Strategy
Table 36. Global Drug Eluting Balloon Catheters Sales by Geographic Region (2021-2026) & (K Units)
Table 37. Global Drug Eluting Balloon Catheters Sales Market Share Geographic Region (2021-2026)
Table 38. Global Drug Eluting Balloon Catheters Revenue by Geographic Region (2021-2026) & ($ millions)
Table 39. Global Drug Eluting Balloon Catheters Revenue Market Share by Geographic Region (2021-2026)
Table 40. Global Drug Eluting Balloon Catheters Sales by Country/Region (2021-2026) & (K Units)
Table 41. Global Drug Eluting Balloon Catheters Sales Market Share by Country/Region (2021-2026)
Table 42. Global Drug Eluting Balloon Catheters Revenue by Country/Region (2021-2026) & ($ millions)
Table 43. Global Drug Eluting Balloon Catheters Revenue Market Share by Country/Region (2021-2026)
Table 44. Americas Drug Eluting Balloon Catheters Sales by Country (2021-2026) & (K Units)
Table 45. Americas Drug Eluting Balloon Catheters Sales Market Share by Country (2021-2026)
Table 46. Americas Drug Eluting Balloon Catheters Revenue by Country (2021-2026) & ($ millions)
Table 47. Americas Drug Eluting Balloon Catheters Sales by Type (2021-2026) & (K Units)
Table 48. Americas Drug Eluting Balloon Catheters Sales by Application (2021-2026) & (K Units)
Table 49. APAC Drug Eluting Balloon Catheters Sales by Region (2021-2026) & (K Units)
Table 50. APAC Drug Eluting Balloon Catheters Sales Market Share by Region (2021-2026)
Table 51. APAC Drug Eluting Balloon Catheters Revenue by Region (2021-2026) & ($ millions)
Table 52. APAC Drug Eluting Balloon Catheters Sales by Type (2021-2026) & (K Units)
Table 53. APAC Drug Eluting Balloon Catheters Sales by Application (2021-2026) & (K Units)
Table 54. Europe Drug Eluting Balloon Catheters Sales by Country (2021-2026) & (K Units)
Table 55. Europe Drug Eluting Balloon Catheters Revenue by Country (2021-2026) & ($ millions)
Table 56. Europe Drug Eluting Balloon Catheters Sales by Type (2021-2026) & (K Units)
Table 57. Europe Drug Eluting Balloon Catheters Sales by Application (2021-2026) & (K Units)
Table 58. Middle East & Africa Drug Eluting Balloon Catheters Sales by Country (2021-2026) & (K Units)
Table 59. Middle East & Africa Drug Eluting Balloon Catheters Revenue Market Share by Country (2021-2026)
Table 60. Middle East & Africa Drug Eluting Balloon Catheters Sales by Type (2021-2026) & (K Units)
Table 61. Middle East & Africa Drug Eluting Balloon Catheters Sales by Application (2021-2026) & (K Units)
Table 62. Key Market Drivers & Growth Opportunities of Drug Eluting Balloon Catheters
Table 63. Key Market Challenges & Risks of Drug Eluting Balloon Catheters
Table 64. Key Industry Trends of Drug Eluting Balloon Catheters
Table 65. Drug Eluting Balloon Catheters Raw Material
Table 66. Key Suppliers of Raw Materials
Table 67. Drug Eluting Balloon Catheters Distributors List
Table 68. Drug Eluting Balloon Catheters Customer List
Table 69. Global Drug Eluting Balloon Catheters Sales Forecast by Region (2027-2032) & (K Units)
Table 70. Global Drug Eluting Balloon Catheters Revenue Forecast by Region (2027-2032) & ($ millions)
Table 71. Americas Drug Eluting Balloon Catheters Sales Forecast by Country (2027-2032) & (K Units)
Table 72. Americas Drug Eluting Balloon Catheters Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 73. APAC Drug Eluting Balloon Catheters Sales Forecast by Region (2027-2032) & (K Units)
Table 74. APAC Drug Eluting Balloon Catheters Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 75. Europe Drug Eluting Balloon Catheters Sales Forecast by Country (2027-2032) & (K Units)
Table 76. Europe Drug Eluting Balloon Catheters Revenue Forecast by Country (2027-2032) & ($ millions)
Table 77. Middle East & Africa Drug Eluting Balloon Catheters Sales Forecast by Country (2027-2032) & (K Units)
Table 78. Middle East & Africa Drug Eluting Balloon Catheters Revenue Forecast by Country (2027-2032) & ($ millions)
Table 79. Global Drug Eluting Balloon Catheters Sales Forecast by Type (2027-2032) & (K Units)
Table 80. Global Drug Eluting Balloon Catheters Revenue Forecast by Type (2027-2032) & ($ millions)
Table 81. Global Drug Eluting Balloon Catheters Sales Forecast by Application (2027-2032) & (K Units)
Table 82. Global Drug Eluting Balloon Catheters Revenue Forecast by Application (2027-2032) & ($ millions)
Table 83. B. Braun Basic Information, Drug Eluting Balloon Catheters Manufacturing Base, Sales Area and Its Competitors
Table 84. B. Braun Drug Eluting Balloon Catheters Product Portfolios and Specifications
Table 85. B. Braun Drug Eluting Balloon Catheters Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. B. Braun Main Business
Table 87. B. Braun Latest Developments
Table 88. Medtronic Basic Information, Drug Eluting Balloon Catheters Manufacturing Base, Sales Area and Its Competitors
Table 89. Medtronic Drug Eluting Balloon Catheters Product Portfolios and Specifications
Table 90. Medtronic Drug Eluting Balloon Catheters Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Medtronic Main Business
Table 92. Medtronic Latest Developments
Table 93. Boston Scientific Basic Information, Drug Eluting Balloon Catheters Manufacturing Base, Sales Area and Its Competitors
Table 94. Boston Scientific Drug Eluting Balloon Catheters Product Portfolios and Specifications
Table 95. Boston Scientific Drug Eluting Balloon Catheters Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Boston Scientific Main Business
Table 97. Boston Scientific Latest Developments
Table 98. BD Basic Information, Drug Eluting Balloon Catheters Manufacturing Base, Sales Area and Its Competitors
Table 99. BD Drug Eluting Balloon Catheters Product Portfolios and Specifications
Table 100. BD Drug Eluting Balloon Catheters Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. BD Main Business
Table 102. BD Latest Developments
Table 103. Yinyi Biotechnology Basic Information, Drug Eluting Balloon Catheters Manufacturing Base, Sales Area and Its Competitors
Table 104. Yinyi Biotechnology Drug Eluting Balloon Catheters Product Portfolios and Specifications
Table 105. Yinyi Biotechnology Drug Eluting Balloon Catheters Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Yinyi Biotechnology Main Business
Table 107. Yinyi Biotechnology Latest Developments
Table 108. Acotec Basic Information, Drug Eluting Balloon Catheters Manufacturing Base, Sales Area and Its Competitors
Table 109. Acotec Drug Eluting Balloon Catheters Product Portfolios and Specifications
Table 110. Acotec Drug Eluting Balloon Catheters Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Acotec Main Business
Table 112. Acotec Latest Developments
Table 113. Philips Basic Information, Drug Eluting Balloon Catheters Manufacturing Base, Sales Area and Its Competitors
Table 114. Philips Drug Eluting Balloon Catheters Product Portfolios and Specifications
Table 115. Philips Drug Eluting Balloon Catheters Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Philips Main Business
Table 117. Philips Latest Developments
Table 118. Lepu Medical Basic Information, Drug Eluting Balloon Catheters Manufacturing Base, Sales Area and Its Competitors
Table 119. Lepu Medical Drug Eluting Balloon Catheters Product Portfolios and Specifications
Table 120. Lepu Medical Drug Eluting Balloon Catheters Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Lepu Medical Main Business
Table 122. Lepu Medical Latest Developments
Table 123. Eurocor Basic Information, Drug Eluting Balloon Catheters Manufacturing Base, Sales Area and Its Competitors
Table 124. Eurocor Drug Eluting Balloon Catheters Product Portfolios and Specifications
Table 125. Eurocor Drug Eluting Balloon Catheters Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Eurocor Main Business
Table 127. Eurocor Latest Developments
Table 128. MicroPort Medical Basic Information, Drug Eluting Balloon Catheters Manufacturing Base, Sales Area and Its Competitors
Table 129. MicroPort Medical Drug Eluting Balloon Catheters Product Portfolios and Specifications
Table 130. MicroPort Medical Drug Eluting Balloon Catheters Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. MicroPort Medical Main Business
Table 132. MicroPort Medical Latest Developments
Table 133. Teleflex Basic Information, Drug Eluting Balloon Catheters Manufacturing Base, Sales Area and Its Competitors
Table 134. Teleflex Drug Eluting Balloon Catheters Product Portfolios and Specifications
Table 135. Teleflex Drug Eluting Balloon Catheters Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. Teleflex Main Business
Table 137. Teleflex Latest Developments
Table 1. Drug Eluting Balloon Catheters Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Drug Eluting Balloon Catheters Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Peripheral DEB
Table 4. Major Players of Coronary DEB
Table 5. Global Drug Eluting Balloon Catheters Sales by Type (2021-2026) & (K Units)
Table 6. Global Drug Eluting Balloon Catheters Sales Market Share by Type (2021-2026)
Table 7. Global Drug Eluting Balloon Catheters Revenue by Type (2021-2026) & ($ million)
Table 8. Global Drug Eluting Balloon Catheters Revenue Market Share by Type (2021-2026)
Table 9. Global Drug Eluting Balloon Catheters Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of In-Stent Restenosi
Table 11. Major Players of De Novo
Table 12. Major Players of Small Vessel
Table 13. Global Drug Eluting Balloon Catheters Sales by Balloon Platform Mechanics (2021-2026) & (K Units)
Table 14. Global Drug Eluting Balloon Catheters Sales Market Share by Balloon Platform Mechanics (2021-2026)
Table 15. Global Drug Eluting Balloon Catheters Revenue by Balloon Platform Mechanics (2021-2026) & ($ million)
Table 16. Global Drug Eluting Balloon Catheters Revenue Market Share by Balloon Platform Mechanics (2021-2026)
Table 17. Global Drug Eluting Balloon Catheters Sale Price by Balloon Platform Mechanics (2021-2026) & (US$/Unit)
Table 18. Major Players of Semi-/Compliant
Table 19. Major Players of Non-compliant
Table 20. Major Players of Other
Table 21. Global Drug Eluting Balloon Catheters Sale by Application (2021-2026) & (K Units)
Table 22. Global Drug Eluting Balloon Catheters Sale Market Share by Application (2021-2026)
Table 23. Global Drug Eluting Balloon Catheters Revenue by Application (2021-2026) & ($ million)
Table 24. Global Drug Eluting Balloon Catheters Revenue Market Share by Application (2021-2026)
Table 25. Global Drug Eluting Balloon Catheters Sale Price by Application (2021-2026) & (US$/Unit)
Table 26. Global Drug Eluting Balloon Catheters Sales by Company (2021-2026) & (K Units)
Table 27. Global Drug Eluting Balloon Catheters Sales Market Share by Company (2021-2026)
Table 28. Global Drug Eluting Balloon Catheters Revenue by Company (2021-2026) & ($ millions)
Table 29. Global Drug Eluting Balloon Catheters Revenue Market Share by Company (2021-2026)
Table 30. Global Drug Eluting Balloon Catheters Sale Price by Company (2021-2026) & (US$/Unit)
Table 31. Key Manufacturers Drug Eluting Balloon Catheters Producing Area Distribution and Sales Area
Table 32. Players Drug Eluting Balloon Catheters Products Offered
Table 33. Drug Eluting Balloon Catheters Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 34. New Products and Potential Entrants
Table 35. Market M&A Activity & Strategy
Table 36. Global Drug Eluting Balloon Catheters Sales by Geographic Region (2021-2026) & (K Units)
Table 37. Global Drug Eluting Balloon Catheters Sales Market Share Geographic Region (2021-2026)
Table 38. Global Drug Eluting Balloon Catheters Revenue by Geographic Region (2021-2026) & ($ millions)
Table 39. Global Drug Eluting Balloon Catheters Revenue Market Share by Geographic Region (2021-2026)
Table 40. Global Drug Eluting Balloon Catheters Sales by Country/Region (2021-2026) & (K Units)
Table 41. Global Drug Eluting Balloon Catheters Sales Market Share by Country/Region (2021-2026)
Table 42. Global Drug Eluting Balloon Catheters Revenue by Country/Region (2021-2026) & ($ millions)
Table 43. Global Drug Eluting Balloon Catheters Revenue Market Share by Country/Region (2021-2026)
Table 44. Americas Drug Eluting Balloon Catheters Sales by Country (2021-2026) & (K Units)
Table 45. Americas Drug Eluting Balloon Catheters Sales Market Share by Country (2021-2026)
Table 46. Americas Drug Eluting Balloon Catheters Revenue by Country (2021-2026) & ($ millions)
Table 47. Americas Drug Eluting Balloon Catheters Sales by Type (2021-2026) & (K Units)
Table 48. Americas Drug Eluting Balloon Catheters Sales by Application (2021-2026) & (K Units)
Table 49. APAC Drug Eluting Balloon Catheters Sales by Region (2021-2026) & (K Units)
Table 50. APAC Drug Eluting Balloon Catheters Sales Market Share by Region (2021-2026)
Table 51. APAC Drug Eluting Balloon Catheters Revenue by Region (2021-2026) & ($ millions)
Table 52. APAC Drug Eluting Balloon Catheters Sales by Type (2021-2026) & (K Units)
Table 53. APAC Drug Eluting Balloon Catheters Sales by Application (2021-2026) & (K Units)
Table 54. Europe Drug Eluting Balloon Catheters Sales by Country (2021-2026) & (K Units)
Table 55. Europe Drug Eluting Balloon Catheters Revenue by Country (2021-2026) & ($ millions)
Table 56. Europe Drug Eluting Balloon Catheters Sales by Type (2021-2026) & (K Units)
Table 57. Europe Drug Eluting Balloon Catheters Sales by Application (2021-2026) & (K Units)
Table 58. Middle East & Africa Drug Eluting Balloon Catheters Sales by Country (2021-2026) & (K Units)
Table 59. Middle East & Africa Drug Eluting Balloon Catheters Revenue Market Share by Country (2021-2026)
Table 60. Middle East & Africa Drug Eluting Balloon Catheters Sales by Type (2021-2026) & (K Units)
Table 61. Middle East & Africa Drug Eluting Balloon Catheters Sales by Application (2021-2026) & (K Units)
Table 62. Key Market Drivers & Growth Opportunities of Drug Eluting Balloon Catheters
Table 63. Key Market Challenges & Risks of Drug Eluting Balloon Catheters
Table 64. Key Industry Trends of Drug Eluting Balloon Catheters
Table 65. Drug Eluting Balloon Catheters Raw Material
Table 66. Key Suppliers of Raw Materials
Table 67. Drug Eluting Balloon Catheters Distributors List
Table 68. Drug Eluting Balloon Catheters Customer List
Table 69. Global Drug Eluting Balloon Catheters Sales Forecast by Region (2027-2032) & (K Units)
Table 70. Global Drug Eluting Balloon Catheters Revenue Forecast by Region (2027-2032) & ($ millions)
Table 71. Americas Drug Eluting Balloon Catheters Sales Forecast by Country (2027-2032) & (K Units)
Table 72. Americas Drug Eluting Balloon Catheters Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 73. APAC Drug Eluting Balloon Catheters Sales Forecast by Region (2027-2032) & (K Units)
Table 74. APAC Drug Eluting Balloon Catheters Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 75. Europe Drug Eluting Balloon Catheters Sales Forecast by Country (2027-2032) & (K Units)
Table 76. Europe Drug Eluting Balloon Catheters Revenue Forecast by Country (2027-2032) & ($ millions)
Table 77. Middle East & Africa Drug Eluting Balloon Catheters Sales Forecast by Country (2027-2032) & (K Units)
Table 78. Middle East & Africa Drug Eluting Balloon Catheters Revenue Forecast by Country (2027-2032) & ($ millions)
Table 79. Global Drug Eluting Balloon Catheters Sales Forecast by Type (2027-2032) & (K Units)
Table 80. Global Drug Eluting Balloon Catheters Revenue Forecast by Type (2027-2032) & ($ millions)
Table 81. Global Drug Eluting Balloon Catheters Sales Forecast by Application (2027-2032) & (K Units)
Table 82. Global Drug Eluting Balloon Catheters Revenue Forecast by Application (2027-2032) & ($ millions)
Table 83. B. Braun Basic Information, Drug Eluting Balloon Catheters Manufacturing Base, Sales Area and Its Competitors
Table 84. B. Braun Drug Eluting Balloon Catheters Product Portfolios and Specifications
Table 85. B. Braun Drug Eluting Balloon Catheters Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. B. Braun Main Business
Table 87. B. Braun Latest Developments
Table 88. Medtronic Basic Information, Drug Eluting Balloon Catheters Manufacturing Base, Sales Area and Its Competitors
Table 89. Medtronic Drug Eluting Balloon Catheters Product Portfolios and Specifications
Table 90. Medtronic Drug Eluting Balloon Catheters Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Medtronic Main Business
Table 92. Medtronic Latest Developments
Table 93. Boston Scientific Basic Information, Drug Eluting Balloon Catheters Manufacturing Base, Sales Area and Its Competitors
Table 94. Boston Scientific Drug Eluting Balloon Catheters Product Portfolios and Specifications
Table 95. Boston Scientific Drug Eluting Balloon Catheters Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Boston Scientific Main Business
Table 97. Boston Scientific Latest Developments
Table 98. BD Basic Information, Drug Eluting Balloon Catheters Manufacturing Base, Sales Area and Its Competitors
Table 99. BD Drug Eluting Balloon Catheters Product Portfolios and Specifications
Table 100. BD Drug Eluting Balloon Catheters Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. BD Main Business
Table 102. BD Latest Developments
Table 103. Yinyi Biotechnology Basic Information, Drug Eluting Balloon Catheters Manufacturing Base, Sales Area and Its Competitors
Table 104. Yinyi Biotechnology Drug Eluting Balloon Catheters Product Portfolios and Specifications
Table 105. Yinyi Biotechnology Drug Eluting Balloon Catheters Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Yinyi Biotechnology Main Business
Table 107. Yinyi Biotechnology Latest Developments
Table 108. Acotec Basic Information, Drug Eluting Balloon Catheters Manufacturing Base, Sales Area and Its Competitors
Table 109. Acotec Drug Eluting Balloon Catheters Product Portfolios and Specifications
Table 110. Acotec Drug Eluting Balloon Catheters Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Acotec Main Business
Table 112. Acotec Latest Developments
Table 113. Philips Basic Information, Drug Eluting Balloon Catheters Manufacturing Base, Sales Area and Its Competitors
Table 114. Philips Drug Eluting Balloon Catheters Product Portfolios and Specifications
Table 115. Philips Drug Eluting Balloon Catheters Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Philips Main Business
Table 117. Philips Latest Developments
Table 118. Lepu Medical Basic Information, Drug Eluting Balloon Catheters Manufacturing Base, Sales Area and Its Competitors
Table 119. Lepu Medical Drug Eluting Balloon Catheters Product Portfolios and Specifications
Table 120. Lepu Medical Drug Eluting Balloon Catheters Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Lepu Medical Main Business
Table 122. Lepu Medical Latest Developments
Table 123. Eurocor Basic Information, Drug Eluting Balloon Catheters Manufacturing Base, Sales Area and Its Competitors
Table 124. Eurocor Drug Eluting Balloon Catheters Product Portfolios and Specifications
Table 125. Eurocor Drug Eluting Balloon Catheters Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Eurocor Main Business
Table 127. Eurocor Latest Developments
Table 128. MicroPort Medical Basic Information, Drug Eluting Balloon Catheters Manufacturing Base, Sales Area and Its Competitors
Table 129. MicroPort Medical Drug Eluting Balloon Catheters Product Portfolios and Specifications
Table 130. MicroPort Medical Drug Eluting Balloon Catheters Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. MicroPort Medical Main Business
Table 132. MicroPort Medical Latest Developments
Table 133. Teleflex Basic Information, Drug Eluting Balloon Catheters Manufacturing Base, Sales Area and Its Competitors
Table 134. Teleflex Drug Eluting Balloon Catheters Product Portfolios and Specifications
Table 135. Teleflex Drug Eluting Balloon Catheters Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. Teleflex Main Business
Table 137. Teleflex Latest Developments
LIST OF FIGURES
Figure 1. Picture of Drug Eluting Balloon Catheters
Figure 2. Drug Eluting Balloon Catheters Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Drug Eluting Balloon Catheters Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Drug Eluting Balloon Catheters Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Drug Eluting Balloon Catheters Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Drug Eluting Balloon Catheters Sales Market Share by Country/Region (2025)
Figure 10. Drug Eluting Balloon Catheters Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Peripheral DEB
Figure 12. Product Picture of Coronary DEB
Figure 13. Global Drug Eluting Balloon Catheters Sales Market Share by Type in 2026
Figure 14. Global Drug Eluting Balloon Catheters Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of In-Stent Restenosi
Figure 16. Product Picture of De Novo
Figure 17. Product Picture of Small Vessel
Figure 18. Global Drug Eluting Balloon Catheters Sales Market Share by Balloon Platform Mechanics in 2026
Figure 19. Global Drug Eluting Balloon Catheters Revenue Market Share by Balloon Platform Mechanics (2021-2026)
Figure 20. Product Picture of Semi-/Compliant
Figure 21. Product Picture of Non-compliant
Figure 22. Product Picture of Other
Figure 23. Drug Eluting Balloon Catheters Consumed in Cardiac Catheterization Lab
Figure 24. Global Drug Eluting Balloon Catheters Market: Cardiac Catheterization Lab (2021-2026) & (K Units)
Figure 25. Drug Eluting Balloon Catheters Consumed in Hospital
Figure 26. Global Drug Eluting Balloon Catheters Market: Hospital (2021-2026) & (K Units)
Figure 27. Drug Eluting Balloon Catheters Consumed in Other
Figure 28. Global Drug Eluting Balloon Catheters Market: Other (2021-2026) & (K Units)
Figure 29. Global Drug Eluting Balloon Catheters Sale Market Share by Application (2025)
Figure 30. Global Drug Eluting Balloon Catheters Revenue Market Share by Application in 2026
Figure 31. Drug Eluting Balloon Catheters Sales by Company in 2026 (K Units)
Figure 32. Global Drug Eluting Balloon Catheters Sales Market Share by Company in 2026
Figure 33. Drug Eluting Balloon Catheters Revenue by Company in 2026 ($ millions)
Figure 34. Global Drug Eluting Balloon Catheters Revenue Market Share by Company in 2026
Figure 35. Global Drug Eluting Balloon Catheters Sales Market Share by Geographic Region (2021-2026)
Figure 36. Global Drug Eluting Balloon Catheters Revenue Market Share by Geographic Region in 2026
Figure 37. Americas Drug Eluting Balloon Catheters Sales 2021-2026 (K Units)
Figure 38. Americas Drug Eluting Balloon Catheters Revenue 2021-2026 ($ millions)
Figure 39. APAC Drug Eluting Balloon Catheters Sales 2021-2026 (K Units)
Figure 40. APAC Drug Eluting Balloon Catheters Revenue 2021-2026 ($ millions)
Figure 41. Europe Drug Eluting Balloon Catheters Sales 2021-2026 (K Units)
Figure 42. Europe Drug Eluting Balloon Catheters Revenue 2021-2026 ($ millions)
Figure 43. Middle East & Africa Drug Eluting Balloon Catheters Sales 2021-2026 (K Units)
Figure 44. Middle East & Africa Drug Eluting Balloon Catheters Revenue 2021-2026 ($ millions)
Figure 45. Americas Drug Eluting Balloon Catheters Sales Market Share by Country in 2026
Figure 46. Americas Drug Eluting Balloon Catheters Revenue Market Share by Country (2021-2026)
Figure 47. Americas Drug Eluting Balloon Catheters Sales Market Share by Type (2021-2026)
Figure 48. Americas Drug Eluting Balloon Catheters Sales Market Share by Application (2021-2026)
Figure 49. United States Drug Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 50. Canada Drug Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 51. Mexico Drug Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 52. Brazil Drug Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 53. APAC Drug Eluting Balloon Catheters Sales Market Share by Region in 2026
Figure 54. APAC Drug Eluting Balloon Catheters Revenue Market Share by Region (2021-2026)
Figure 55. APAC Drug Eluting Balloon Catheters Sales Market Share by Type (2021-2026)
Figure 56. APAC Drug Eluting Balloon Catheters Sales Market Share by Application (2021-2026)
Figure 57. China Drug Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 58. Japan Drug Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 59. South Korea Drug Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 60. Southeast Asia Drug Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 61. India Drug Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 62. Australia Drug Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 63. China Taiwan Drug Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 64. Europe Drug Eluting Balloon Catheters Sales Market Share by Country in 2026
Figure 65. Europe Drug Eluting Balloon Catheters Revenue Market Share by Country (2021-2026)
Figure 66. Europe Drug Eluting Balloon Catheters Sales Market Share by Type (2021-2026)
Figure 67. Europe Drug Eluting Balloon Catheters Sales Market Share by Application (2021-2026)
Figure 68. Germany Drug Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 69. France Drug Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 70. UK Drug Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 71. Italy Drug Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 72. Russia Drug Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 73. Middle East & Africa Drug Eluting Balloon Catheters Sales Market Share by Country (2021-2026)
Figure 74. Middle East & Africa Drug Eluting Balloon Catheters Sales Market Share by Type (2021-2026)
Figure 75. Middle East & Africa Drug Eluting Balloon Catheters Sales Market Share by Application (2021-2026)
Figure 76. Egypt Drug Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 77. South Africa Drug Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 78. Israel Drug Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 79. Turkey Drug Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 80. GCC Countries Drug Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 81. Manufacturing Cost Structure Analysis of Drug Eluting Balloon Catheters in 2026
Figure 82. Manufacturing Process Analysis of Drug Eluting Balloon Catheters
Figure 83. Industry Chain Structure of Drug Eluting Balloon Catheters
Figure 84. Channels of Distribution
Figure 85. Global Drug Eluting Balloon Catheters Sales Market Forecast by Region (2027-2032)
Figure 86. Global Drug Eluting Balloon Catheters Revenue Market Share Forecast by Region (2027-2032)
Figure 87. Global Drug Eluting Balloon Catheters Sales Market Share Forecast by Type (2027-2032)
Figure 88. Global Drug Eluting Balloon Catheters Revenue Market Share Forecast by Type (2027-2032)
Figure 89. Global Drug Eluting Balloon Catheters Sales Market Share Forecast by Application (2027-2032)
Figure 90. Global Drug Eluting Balloon Catheters Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Drug Eluting Balloon Catheters
Figure 2. Drug Eluting Balloon Catheters Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Drug Eluting Balloon Catheters Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Drug Eluting Balloon Catheters Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Drug Eluting Balloon Catheters Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Drug Eluting Balloon Catheters Sales Market Share by Country/Region (2025)
Figure 10. Drug Eluting Balloon Catheters Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Peripheral DEB
Figure 12. Product Picture of Coronary DEB
Figure 13. Global Drug Eluting Balloon Catheters Sales Market Share by Type in 2026
Figure 14. Global Drug Eluting Balloon Catheters Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of In-Stent Restenosi
Figure 16. Product Picture of De Novo
Figure 17. Product Picture of Small Vessel
Figure 18. Global Drug Eluting Balloon Catheters Sales Market Share by Balloon Platform Mechanics in 2026
Figure 19. Global Drug Eluting Balloon Catheters Revenue Market Share by Balloon Platform Mechanics (2021-2026)
Figure 20. Product Picture of Semi-/Compliant
Figure 21. Product Picture of Non-compliant
Figure 22. Product Picture of Other
Figure 23. Drug Eluting Balloon Catheters Consumed in Cardiac Catheterization Lab
Figure 24. Global Drug Eluting Balloon Catheters Market: Cardiac Catheterization Lab (2021-2026) & (K Units)
Figure 25. Drug Eluting Balloon Catheters Consumed in Hospital
Figure 26. Global Drug Eluting Balloon Catheters Market: Hospital (2021-2026) & (K Units)
Figure 27. Drug Eluting Balloon Catheters Consumed in Other
Figure 28. Global Drug Eluting Balloon Catheters Market: Other (2021-2026) & (K Units)
Figure 29. Global Drug Eluting Balloon Catheters Sale Market Share by Application (2025)
Figure 30. Global Drug Eluting Balloon Catheters Revenue Market Share by Application in 2026
Figure 31. Drug Eluting Balloon Catheters Sales by Company in 2026 (K Units)
Figure 32. Global Drug Eluting Balloon Catheters Sales Market Share by Company in 2026
Figure 33. Drug Eluting Balloon Catheters Revenue by Company in 2026 ($ millions)
Figure 34. Global Drug Eluting Balloon Catheters Revenue Market Share by Company in 2026
Figure 35. Global Drug Eluting Balloon Catheters Sales Market Share by Geographic Region (2021-2026)
Figure 36. Global Drug Eluting Balloon Catheters Revenue Market Share by Geographic Region in 2026
Figure 37. Americas Drug Eluting Balloon Catheters Sales 2021-2026 (K Units)
Figure 38. Americas Drug Eluting Balloon Catheters Revenue 2021-2026 ($ millions)
Figure 39. APAC Drug Eluting Balloon Catheters Sales 2021-2026 (K Units)
Figure 40. APAC Drug Eluting Balloon Catheters Revenue 2021-2026 ($ millions)
Figure 41. Europe Drug Eluting Balloon Catheters Sales 2021-2026 (K Units)
Figure 42. Europe Drug Eluting Balloon Catheters Revenue 2021-2026 ($ millions)
Figure 43. Middle East & Africa Drug Eluting Balloon Catheters Sales 2021-2026 (K Units)
Figure 44. Middle East & Africa Drug Eluting Balloon Catheters Revenue 2021-2026 ($ millions)
Figure 45. Americas Drug Eluting Balloon Catheters Sales Market Share by Country in 2026
Figure 46. Americas Drug Eluting Balloon Catheters Revenue Market Share by Country (2021-2026)
Figure 47. Americas Drug Eluting Balloon Catheters Sales Market Share by Type (2021-2026)
Figure 48. Americas Drug Eluting Balloon Catheters Sales Market Share by Application (2021-2026)
Figure 49. United States Drug Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 50. Canada Drug Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 51. Mexico Drug Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 52. Brazil Drug Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 53. APAC Drug Eluting Balloon Catheters Sales Market Share by Region in 2026
Figure 54. APAC Drug Eluting Balloon Catheters Revenue Market Share by Region (2021-2026)
Figure 55. APAC Drug Eluting Balloon Catheters Sales Market Share by Type (2021-2026)
Figure 56. APAC Drug Eluting Balloon Catheters Sales Market Share by Application (2021-2026)
Figure 57. China Drug Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 58. Japan Drug Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 59. South Korea Drug Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 60. Southeast Asia Drug Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 61. India Drug Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 62. Australia Drug Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 63. China Taiwan Drug Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 64. Europe Drug Eluting Balloon Catheters Sales Market Share by Country in 2026
Figure 65. Europe Drug Eluting Balloon Catheters Revenue Market Share by Country (2021-2026)
Figure 66. Europe Drug Eluting Balloon Catheters Sales Market Share by Type (2021-2026)
Figure 67. Europe Drug Eluting Balloon Catheters Sales Market Share by Application (2021-2026)
Figure 68. Germany Drug Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 69. France Drug Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 70. UK Drug Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 71. Italy Drug Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 72. Russia Drug Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 73. Middle East & Africa Drug Eluting Balloon Catheters Sales Market Share by Country (2021-2026)
Figure 74. Middle East & Africa Drug Eluting Balloon Catheters Sales Market Share by Type (2021-2026)
Figure 75. Middle East & Africa Drug Eluting Balloon Catheters Sales Market Share by Application (2021-2026)
Figure 76. Egypt Drug Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 77. South Africa Drug Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 78. Israel Drug Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 79. Turkey Drug Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 80. GCC Countries Drug Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 81. Manufacturing Cost Structure Analysis of Drug Eluting Balloon Catheters in 2026
Figure 82. Manufacturing Process Analysis of Drug Eluting Balloon Catheters
Figure 83. Industry Chain Structure of Drug Eluting Balloon Catheters
Figure 84. Channels of Distribution
Figure 85. Global Drug Eluting Balloon Catheters Sales Market Forecast by Region (2027-2032)
Figure 86. Global Drug Eluting Balloon Catheters Revenue Market Share Forecast by Region (2027-2032)
Figure 87. Global Drug Eluting Balloon Catheters Sales Market Share Forecast by Type (2027-2032)
Figure 88. Global Drug Eluting Balloon Catheters Revenue Market Share Forecast by Type (2027-2032)
Figure 89. Global Drug Eluting Balloon Catheters Sales Market Share Forecast by Application (2027-2032)
Figure 90. Global Drug Eluting Balloon Catheters Revenue Market Share Forecast by Application (2027-2032)
